Header Logo

Connection

BRETT CARTER to Circulating Tumor DNA

Back to Details
This is a "connection" page, showing publications BRETT CARTER has written about Circulating Tumor DNA.
BRETT CARTER
Connection Strength
0.162
Circulating Tumor DNA
  1. Clinical Outcomes in Non-Small-Cell Lung Cancer Patients Treated With EGFR-Tyrosine Kinase Inhibitors and Other Targeted Therapies Based on Tumor Versus Plasma Genomic Profiling. JCO Precis Oncol. 2021 08; 5.
    View in: PubMed
    Score: 0.162
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.